Abstract
Although endothelial cells are not immunological cells in sensu stricto, they play an important role in controlling inflammation/immune responses. The endothelium is involved in a wide range of pathologies, the most common being vascular diseases and cancer, and they also are central to transplant rejection. Genetic modification of endothelium allows different strategies for inducing tolerance, modulating inflammation, stimulating the immune response or inhibiting the formation of new blood vessels. In this context, the lack of effective and specific pharmacological interventions renders endothelial cells extremely attractive for gene therapy applications. Despite efforts made to genetically modify endothelial cells, the results obtained have suffered from the differences of the endothelium at the different anatomical sites. Several studies are currently being developed to specifically target endothelium using viral and non viral gene delivery approaches. We highlight here some strategies used for genetically manipulating endothelial cells with the aim of inducing tolerance to allograft, or enhancing immunity and/or inhibiting uncontrolled endothelial cell proliferation in tumours.
Keywords: Endothelial cells, gene transfer, gene delivery, inflammation, immune response
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Modulation of the Immune Response by Targeting Endothelial Cells
Volume: 6 Issue: 2
Author(s): Maria Manunta, Peng Hong Tan and Andrew John Timothy George
Affiliation:
Keywords: Endothelial cells, gene transfer, gene delivery, inflammation, immune response
Abstract: Although endothelial cells are not immunological cells in sensu stricto, they play an important role in controlling inflammation/immune responses. The endothelium is involved in a wide range of pathologies, the most common being vascular diseases and cancer, and they also are central to transplant rejection. Genetic modification of endothelium allows different strategies for inducing tolerance, modulating inflammation, stimulating the immune response or inhibiting the formation of new blood vessels. In this context, the lack of effective and specific pharmacological interventions renders endothelial cells extremely attractive for gene therapy applications. Despite efforts made to genetically modify endothelial cells, the results obtained have suffered from the differences of the endothelium at the different anatomical sites. Several studies are currently being developed to specifically target endothelium using viral and non viral gene delivery approaches. We highlight here some strategies used for genetically manipulating endothelial cells with the aim of inducing tolerance to allograft, or enhancing immunity and/or inhibiting uncontrolled endothelial cell proliferation in tumours.
Export Options
About this article
Cite this article as:
Manunta Maria, Hong Tan Peng and John Timothy George Andrew, Modulation of the Immune Response by Targeting Endothelial Cells, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2007; 6 (2) . https://dx.doi.org/10.2174/187152307780598045
DOI https://dx.doi.org/10.2174/187152307780598045 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulatory T Cells in Central Nervous System: in Health and Disease
Central Nervous System Agents in Medicinal Chemistry Mediterranean Diet and Dementia of the Alzheimer Type
Current Aging Science Berberine in the Treatment of Diabetes Mellitus: A Review
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Selections
Recent Patents on Biotechnology Perinatal Heart Programming: Long-term Consequences
Current Medicinal Chemistry Role of the Sex Hormone Estrogen in the Prevention of Lipid Disorder
Current Medicinal Chemistry Integrated Nutritional Supports for Diabetic Patients During COVID-19 Infection: A Comprehensive Review
Current Diabetes Reviews The Role of Xanthine Oxidase Inhibitors in Patients with History of Stroke: A Systematic Review
Current Vascular Pharmacology Mechanisms for Targeted Delivery of Nanoparticles in Cancer
Current Pharmaceutical Design Hypolipidaemic Drug Treatment: Yesterday is Not Gone Yet, Today is Challenging and Tomorrow is Coming Soon; let us Combine them all
Current Pharmaceutical Design Angiotensin II-Induced Signaling Pathways in Diabetes
Current Diabetes Reviews Therapeutic Use of Vitamin D and its Analogues in Autoimmunity
Recent Patents on Inflammation & Allergy Drug Discovery Diagnosis and Treatment of Dyslipidaemias in Athletes
Current Vascular Pharmacology Systemic Vasculitis: An Epidemiological Perspective
Current Immunology Reviews (Discontinued) Effects of Amine Oxidases in Allergic and Histamine-Mediated Conditions
Recent Patents on Inflammation & Allergy Drug Discovery Glucocorticoids in Pregnancy
Current Pharmaceutical Biotechnology HPA Axis Function During the Perinatal Period in Patients with Affective Disorders
Current Psychiatry Reviews Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
Current Vascular Pharmacology From Multiple PAR1 Receptor/Protein Interactions to their Multiple Therapeutic Implications
Current Topics in Medicinal Chemistry Pulmonary Hypertension and Lung Transplant in Connective Tissue Disease-Interstitial Lung Disease
Current Respiratory Medicine Reviews